Home / Media Center / News

Search

TRINITY LIFE SCIENCES LAUNCHES CONTRACT ANALYTICS OFFERING, ALLOWING LIFE SCIENCES COMPANIES TO CONFIDENTLY NAVIGATE U.S. CONTRACTING AND GROSS-TO-NET DECISION-MAKING

Upcoming Webinar “Confident Contracting: Optimize and Accelerate Key Decisions with Tech-Enabled Impact Projections” Pinpoints Ways to Streamline the Contracting Process by Forecasting the Impact of Individual Contract Strategies Waltham, MA, March 1, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Trinity Contract Analytics, an offering that enhances U.S. payer and provider contract strategy decisions with cloud-based modeling, scenario planning and analytics. Though contracting is an incredibly vital piece of a life sciences company’s U.S.…

Read Now

FIVE KEY GLOBAL MARKET ACCESS TRENDS FROM 2022 THAT WILL IMPACT LIFE SCIENCES ORGANIZATIONS IN 2023

New Thought Leadership Paper Available Now from Trinity Life Sciences Waltham, MA, February 7, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, releases a white paper entitled Global Market Access Trends: 2022 Edition that identifies the five key market access trends that life sciences executives should understand to ensure their organizations are prepared for the year ahead. Results from a survey conducted by Trinity Life Sciences in late 2022 using a sample of 11 U.S.…

Read Now

HAVAS HEALTH & YOU AND TRINITY LIFE SCIENCES ANNOUNCE STRATEGIC PARTNERSHIP

San Francisco, CA – 41st Annual J.P. Morgan Healthcare Conference, January 10, 2023 – Trinity Life Sciences, a global leader in life sciences solutions, and Havas Health & You (HHY&Y), the world’s largest global health and wellness network and part of Havas Group, a Vivendi (VIV) business, today announced a strategic partnership that will allow both companies to offer cohesive end-to-end commercial solutions to the life sciences industry. The partnership includes Havas Health & You taking a minority investment in…

Read Now

TRINITY LIFE SCIENCES ANNOUNCES THE APPOINTMENT OF PAUL R. LUCCHESE AS GENERAL COUNSEL

Waltham, MA, December 14, 2022 – Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Paul R. Lucchese as General Counsel and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s Chief Financial Officer and Head of Corporate Operations. He will be responsible for leading Trinity’s legal operations and global compliance activities. Mr. Lucchese has extensive experience as a General Counsel in high-growth technology-forward organizations including Aspect Software, Candela Corporation,…

Read Now

NRDL INCLUSION OFFERS SUBSTANTIAL OPPORTUNITIES FOR INNOVATIVE, CLINICALLY DIFFERENTIATED THERAPIES IN CHINA DESPITE STEEP PRICE REDUCTIONS

“Cracking the Code of the Access Landscape in China: Analysis of the 2021 NRDL Update” Available Now from Trinity Life Sciences Waltham, MA, December 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that inclusion on the National Reimbursement Drug List (NRDL) offers substantial opportunities for innovative, clinically differentiated therapies in China despite steep price reductions. According to a new white paper entitled Cracking the Code of the Access Landscape in China: Analysis of…

Read Now

NEW ADVISORY BRIEF AND PODCAST REVEAL WHAT LIFE SCIENCES COMPANIES NEED TO KNOW TO BE PREPARED FOR 2023

Waltham, MA, November 30, 2022 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know To Be Prepared for 2023” and its podcast episode “What Leaders In Life Sciences Need To Know To Be Prepared for 2023” based on highlights presented at the TGaS Advisors’ 2022 Fall Client Summit. The TGaS 2022 Fall Client Summit was held in October at the W Hotel Philadelphia with nearly…

Read Now

TRINITY LIFE SCIENCES ILLUMINATES OPTIMAL COMPETITIVE INTELLIGENCE APPROACHES WITH QUALITATIVE STUDY

New E-book “Successfully Navigating the Sea of Competitive Intelligence in Life Sciences” Illustrates How Companies are Handling the Volume and Velocity of Data Waltham, MA, November 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, sees competitive intelligence (CI) leaders in life sciences moving beyond data mining and monitoring to deliver accurate, robust insights. As there is more information becoming available at an ever-increasing pace, it has become more difficult to sift through and find…

Read Now

DIGITAL MARKETING COMPETENCY REPORT REVEALS 2022 RANKING OF BIOPHARMA BRANDS BASED ON DIGITAL PATIENT EXPERIENCES

Waltham, MA, November 15, 2022 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its second annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital patient experiences. The novel study evaluates the brands across five categories and 60 unique metrics to understand each one’s digital marketing presence. The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of…

Read Now

TRINITY LIFE SCIENCES LAUNCHES QUICK PAYER PULSE, ALLOWING CLIENTS TO VALIDATE PRICING AND ACCESS ASSUMPTIONS IN DAYS

Upcoming Webinar “Business Development: Getting Pricing & Access Inputs Right” Tackles the Most Common High-Impact Challenges Inherent in Business Development Waltham, MA, October 27, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Quick Payer Pulse—a proprietary survey tool that generates and quantifies country-specific payer insights to support time-sensitive business needs. In life sciences, pricing and access are vital to an asset’s success globally. As assets go through earlier development phases or M&A processes, there…

Read Now

HOLISTIC, FLEXIBLE PATIENT JOURNEY MODEL REPLACES TRADITIONAL CLINICAL PATHWAY THINKING IN NEW ADVISORY BRIEF

“Patient Journey: A New Approach to Meet the Demands of Patient Centricity” Available Now from Trinity Life Sciences Waltham, MA, September 27, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, outlines a new approach to Patient Journey that allows patient-centric organizations to engage on a meaningful level with patients. As patients continue to expand their role in healthcare choice and treatment decision-making, expectations have grown for pharma to provide an experience in line with well-known,…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.